Stephanie L Goff
Stephanie L Goff
National Cancer Institute
Verified email at
Cited by
Cited by
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
ME Dudley, JC Yang, R Sherry, MS Hughes, R Royal, U Kammula, ...
Journal of Clinical Oncology 26 (32), 5233, 2008
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade
SG Downey, JA Klapper, FO Smith, JC Yang, RM Sherry, RE Royal, ...
Clinical Cancer Research 13 (22), 6681-6688, 2007
High‐dose interleukin‐2 for the treatment of metastatic renal cell carcinoma: a retrospective analysis of response and survival in patients treated in the surgery branch at the …
JA Klapper, SG Downey, FO Smith, JC Yang, MS Hughes, US Kammula, ...
Cancer 113 (2), 293-301, 2008
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
N Zacharakis, H Chinnasamy, M Black, H Xu, YC Lu, Z Zheng, A Pasetto, ...
Nature medicine 24 (6), 724-730, 2018
Lymphoma remissions caused by anti-CD19 chimeric antigen receptor T cells are associated with high serum interleukin-15 levels
JN Kochenderfer, RPT Somerville, T Lu, V Shi, A Bot, J Rossi, A Xue, ...
Journal of Clinical Oncology 35 (16), 1803, 2017
Treatment of metastatic melanoma using interleukin-2 alone or in conjunction with vaccines
FO Smith, SG Downey, JA Klapper, JC Yang, RM Sherry, RE Royal, ...
Clinical Cancer Research 14 (17), 5610-5618, 2008
Randomized, prospective evaluation comparing intensity of lymphodepletion before adoptive transfer of tumor-infiltrating lymphocytes for patients with metastatic melanoma
SL Goff, ME Dudley, DE Citrin, RP Somerville, JR Wunderlich, ...
Journal of Clinical Oncology 34 (20), 2389, 2016
Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study
SS Chandran, RPT Somerville, JC Yang, RM Sherry, CA Klebanoff, ...
The Lancet Oncology 18 (6), 792-802, 2017
Treatment of patients with metastatic cancer using a major histocompatibility complex class II–restricted T-cell receptor targeting the cancer germline antigen MAGE-A3
YC Lu, LL Parker, T Lu, Z Zheng, MA Toomey, DE White, X Yao, YF Li, ...
Journal of Clinical Oncology 35 (29), 3322, 2017
Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL
SL Goff, FO Smith, JA Klapper, R Sherry, JR Wunderlich, SM Steinberg, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 33 (8), 840, 2010
Adoptive cell therapy—tumor-infiltrating lymphocytes, T-cell receptors, and chimeric antigen receptors
SA Feldman, Y Assadipour, I Kriley, SL Goff, SA Rosenberg
Seminars in oncology 42 (4), 626, 2015
Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibody
FO Smith, SL Goff, JA Klapper, C Levy, T Allen, SA Mavroukakis, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 30 (1), 130, 2007
Pilot trial of adoptive transfer of chimeric antigen receptor transduced T cells targeting EGFRvIII in patients with glioblastoma
SL Goff, RA Morgan, JC Yang, RM Sherry, PF Robbins, NP Restifo, ...
Journal of immunotherapy (Hagerstown, Md.: 1997) 42 (4), 126, 2019
Post-shunt resource consumption favors small-diameter prosthetic H-graft portacaval shunt over TIPS for patients with poor hepatic reserve
AS Rosemurgy, EE Zervos, M Bloomston, AJ Durkin, WC Clark, S Goff
Annals of surgery 237 (6), 820, 2003
Enhanced receptor expression and in vitro effector function of a murine-human hybrid MART-1-reactive T cell receptor following a rapid expansion
SL Goff, LA Johnson, MA Black, H Xu, Z Zheng, CJ Cohen, RA Morgan, ...
Cancer immunology, immunotherapy 59 (10), 1551-1560, 2010
Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers
MR Parkhurst, PF Robbins, E Tran, TD Prickett, JJ Gartner, L Jia, G Ivey, ...
Cancer discovery 9 (8), 1022-1035, 2019
Characterization of an immunogenic mutation in a patient with metastatic triple-negative breast cancer
Y Assadipour, N Zacharakis, JS Crystal, TD Prickett, JJ Gartner, ...
Clinical Cancer Research 23 (15), 4347-4353, 2017
Neoadjuvant therapy for non-metastatic pancreatic ductal adenocarcinoma
M Winner, SL Goff, JA Chabot
Seminars in oncology 42 (1), 86-97, 2015
Metastasectomy following immunotherapy with adoptive cell transfer for patients with advanced melanoma
ND Klemen, PL Feingold, SL Goff, MS Hughes, US Kammula, JC Yang, ...
Annals of surgical oncology 24 (1), 135-141, 2017
No correlation between clinical response to CTLA-4 blockade and presence of NY-ESO-1 antibody in patients with metastatic melanoma
SL Goff, PF Robbins, M El-Gamil, SA Rosenberg
Journal of immunotherapy (Hagerstown, Md.: 1997) 32 (8), 884, 2009
The system can't perform the operation now. Try again later.
Articles 1–20